We've highlighted a space opera, a monster movie, a straight-up skin flick, and more forgotten '60s sci-fi movies that ...

Poster presentation and conference exhibit will feature early preclinical data on the Company’s fully implantable, autoregulating artificial heart platform ...

Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases, today announced its ...

Eva Mendes planted a kiss on her longtime partner Ryan Gosling's face — on a poster for his new movie — when she attended ...

The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial ...

Does HTC-19 have an identity that is distinct from that of other chromatography conferences? A: The HTC conference traditionally attracts a relatively large number of participa ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...

The Retreat Committee (pictured) and other participants of the Vision Science Research Center Retreat heard from Michael ...

Fifty-six first-year pre-medical students at Weill Cornell Medicine-Qatar (WCM-Q) in February presented posters from their ...

This partnership reflects a shared commitment by both organizations to advance excellence, quality, and education in ...

The Physicians Committee for Responsible Medicine’s scientists and policy experts are heading to the 65th Annual Meeting of the Society of Toxicology (SOT), where thousands of toxicologists, ...

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.